S5 - E1.6 - SurfingMASH Is Back! How Can Consumer Behavior Confound MASH Care?
Send us a text After a month off in January, SurfingMASH returns for the 2024 calendar year. In this last segment of Episode 1, the co-hosts explore the complexities surrounding advertising and accessibility of metabolic agents in the US market, with a particular focus on how these factors might influence public engagement and healthcare provider education. The tone of this segment demonstrates concern that gaps or inaccuracies in consumer information might affect patient treatment in the ca...
11 Feb 20247min
S5 -E1.5 - SurfingMASH Is Back! How Will GLP-1 Ads From Telemedicine Affect MASH?
Send us a text After a month off in January, SurfingMASH returns for the 2024 calendar year. In this conversation, the group examines the explosion of telemarketer-driven consumer advertising for GLP-1 agents as anti-obesity medicines and asks what impact this might have on diagnosis, treatment and monitoring of MASH in the US. Specifically, the participants discuss the potential impact and concerns surrounding the use of weight-loss drugs, including semaglutide, and the impending appr...
11 Feb 20248min
S5 - E1.4 - SurfingMASH Is Back! Reframing "Liver Awareness" In The Context Of US DTC Advertising
Send us a text After a month off in January, SurfingMASH returns for the 2024 calendar year. In this conversation, the group explores the goal of provider and patient liver education, key goals for liver awareness and the potential for direct-to-consumer advertising of GLP-1s for weight loss to garble the "liver awareness" message. The dialogue underscores the concern that the convenience of telemedicine and the allure of easily accessible obesity treatments might lead patients to over...
11 Feb 20249min
S5 - E1.3 - SurfingMASH Is Back! 2024 Podcast Updates And The Increasing Need For "Liver Awareness"
Send us a text After a month off in January, SurfingMASH returns for the 2024 calendar year. In this conversation, Louise Campbell describes how VCTE can serve as a behavioral monitor, Roger Green reviews some changes in the podcast this year and the group begins to discuss why "liver awareness" should become an important concept. As this conversation starts, a joke from Roger Green about "VCTE as lie detector" leads Louise Campbell to note that personal trainers should consider lookin...
10 Feb 20248min
S5 - E1.2 - SurfingMASH Is Back! Louise Campbell Discusses Building MyLife365.Me And Expanding To New Markets
Send us a text After a month off in January, SurfingMASH returns for the 2024 calendar year. In this conversation, Louise Campbell describes her recent efforts in enhancing liver health awareness and education, focusing on the launch of the user-friendly website MyLife365.me. Also, she shares lessons about patient communication and creating liver awareness. This conversation combines an informal discussion on best ways to deliver information to patients with some more formal thought about go...
10 Feb 20249min
S5 - E1.1 - SurfingMASH Is Back! Jörn Schattenberg On Becoming Department Director At Saarlands
Send us a text After a month off in January, SurfingMASH returns for the 2024 calendar year. In this conversation, Jörn Schattenberg describes the challenges, opportunities and experiences that he has found in assuming Department leadership at the University of the Saarlandes. Jörn shares his early experiences and aspirations as the new chair of a department, emphasizing the joys and challenges of transitioning into this leadership role. He lists the department's strengths and id...
10 Feb 20247min
S5 - E1 - How might approval of a MASH drug affect patient treatment?
Send us a text The first episode of Season 5 of Surfing the MASH Tsunami starts with a brief discussion of what the co-hosts have worked on for the last two months and proceeds to consider the impact on patient treatment of having a MASH drug approved in the US market, particularly in today's direct-to-consumer weight loss advertising. The conversation starts with Jörn Schattenberg discussing his first two months as a Department Chair, focusing on the transition, challenges, and opportunitie...
8 Feb 202447min
S4 E50.11 - Wrapping Up 2023 - An Interview with Global Liver Institute Vice President, Liver Health Programs, Jeff McIntyre
Send us a text Surfing the MASH Tsunami continues its 2023 wrap-up conversations with Global Liver Institute Vice President of Liver Health Programs Jeff McIntyre, along with co-hosts Louise Campbell and Roger Green. The conversation focuses on Jeff's mixed assessment of 2023, focusing largely on drug approvals and the new nomenclature. In 2023, the field of fatty liver disease experienced both setbacks and progress, encapsulated in Jeff's phrase, "Two steps back, one step forward." C...
17 Jan 202438min
